The WNT/β-catenin signaling pathway, in which sclerostin plays a role, also interacts with other signaling pathways, such as the bone morphogenetic protein pathway, to collectively regulate CKD-MBD (Zhang et al., 2023). The gene discussed is SOST; the disease is chronic kidney disease.